Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 277

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Effect of Vitamin D3on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels: The VIDA Randomized Clinical Trial

Open access
Castro, Mario, King, Tonya S., Kunselman, Susan J., Cabana, Michael D., Denlinger, Loren, Holguin, Fernando, Kazani, Shamsah D., Moore, Wendy C., Moy, James, Sorkness, Christine A., Avila, Pedro, Bacharier, Leonard B., Bleecker, Eugene, Boushey, Homer A., Chmiel, James, Fitzpatrick, Anne M., Gentile, Deborah, Hundal, Mandeep, Israel, Elliot, Kraft, Monica, Krishnan, Jerry A., LaForce, Craig, Lazarus, Stephen C., Lemanske, Robert, Lugogo, Njira, Martin, Richard J., Mauger, David T., Naureckas, Edward, Peters, Stephen P., Phipatanakul, Wanda, Que, Loretta G., Sheshadri, Ajay, Smith, Lewis, Solway, Julian, Sullivan-Vedder, Lisa, Sumino, Kaharu, Wechsler, Michael E., Wenzel, Sally, White, Steven R., Sutherland, E. Rand·2014·JAMA

Abstract

IMPORTANCE: In asthma and other diseases, vitamin D insufficiency is associated with adverse outcomes. It is not known if supplementing inhaled corticosteroids with oral vitamin D3 improves outcomes in patients with asthma and vitamin D insufficiency. OBJECTIVE: To evaluate if vitamin D supplementation would improve the clinical efficacy of inhaled corticosteroids in patients with symptomatic asthma and lower vitamin D levels. DESIGN, SETTING, AND PARTICIPANTS: The VIDA (Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma) randomized, double-blind, parallel, placebo-controlled trial studying adult patients with symptomatic asthma and a serum 25-hydroxyvitamin D level of less than 30 ng/mL was conducted across 9 academic US medical centers in the National Heart, Lung, and Blood Institute's AsthmaNet network, with enrollment starting in April 2011 and follow-up complete by January 2014. After a run-in period that included treatment with an inhaled corticosteroid, 408 patients were randomized. INTERVENTIONS: Oral vitamin D3 (100,000 IU once, then 4000 IU/d for 28 weeks; n = 201) or placebo (n = 207) was added to inhaled ciclesonide (320 µg/d). If asthma control was achieved after 12 weeks, ciclesonide was tapered to 160 µg/d for 8 weeks, then to 80 µg/d for 8 weeks if asthma control was maintained. MAIN OUTCOMES AND MEASURES: The primary outcome was time to first asthma treatment failure (a composite outcome of decline in lung function and increases in use of β-agonists, systemic corticosteroids, and health care). RESULTS: Treatment with vitamin D3 did not alter the rate of first treatment failure during 28 weeks (28% [95% CI, 21%-34%] with vitamin D3 vs 29% [95% CI, 23%-35%] with placebo; adjusted hazard ratio, 0.9 [95% CI, 0.6-1.3]). Of 14 prespecified secondary outcomes, 9 were analyzed, including asthma exacerbation; of those 9, the only statistically significant outcome was a small difference in the overall dose of ciclesonide required to maintain asthma control (111.3 µg/d [95% CI, 102.2-120.4 µg/d] in the vitamin D3 group vs 126.2 µg/d [95% CI, 117.2-135.3 µg/d] in the placebo group; difference of 14.9 µg/d [95% CI, 2.1-27.7 µg/d]). CONCLUSIONS AND RELEVANCE: Vitamin D3 did not reduce the rate of first treatment failure or exacerbation in adults with persistent asthma and vitamin D insufficiency. These findings do not support a strategy of therapeutic vitamin D3 supplementation in patients with symptomatic asthma. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01248065.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jama.2014.5052

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 277

Metadata

Authors
Castro, M., King, T. S., Kunselman, S. J., Cabana, M. D., Denlinger, L., Holguin, F., Kazani, S. D., Moore, W. C., Moy, J., Sorkness, C. A., Avila, P., Bacharier, L. B., Bleecker, E., Boushey, H. A., Chmiel, J., Fitzpatrick, A. M., Gentile, D., Hundal, M., Israel, E., Kraft, M., Krishnan, J. A., LaForce, C., Lazarus, S. C., Lemanske, R., Lugogo, N., Martin, R. J., Mauger, D. T., Naureckas, E., Peters, S. P., Phipatanakul, W., Que, L. G., Sheshadri, A., Smith, L., Solway, J., Sullivan-Vedder, L., Sumino, K., Wechsler, M. E., Wenzel, S., White, S. R., & Sutherland, E. R.
Venue
JAMA
Published
2014-05-28
Volume
311
Issue
20
Pages
2083
ISSN
  • 0002-9955 (ISSN-L)
  • 0098-7484
OpenAlex
W2088340450
Cited by
277
References
29
FWCI
29.66
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Vitamin D3on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels: The VIDA Randomized Clinical Trial. https://app.cochat.ai/papers/10.1001/jama.2014.5052
The paper
Castro, M., King, T. S., Kunselman, S. J., Cabana, M. D., Denlinger, L., Holguin, F., Kazani, S. D., Moore, W. C., Moy, J., Sorkness, C. A., Avila, P., Bacharier, L. B., Bleecker, E., Boushey, H. A., Chmiel, J., Fitzpatrick, A. M., Gentile, D., Hundal, M., Israel, E., . . . Sutherland, E. R. (2014). Effect of Vitamin D3on Asthma Treatment Failures in Adults With Symptomatic Asthma and Lower Vitamin D Levels: The VIDA Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2014.5052

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.